Inventor
LEADBETTER MICHAEL ROBERT
US10 patents
⚠️ This page may combine multiple inventors who share the name “LEADBETTER MICHAEL ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARDELYX INC
9 patentsUS9408840B2Aug 9, 2016
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder
ARDELYX INC6 citations83
US11318129B2May 3, 2022
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC1 citations72
US10543207B2Jan 28, 2020
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC3 citations72
US10968246B2Apr 6, 2021
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
ARDELYX INC2 citations71
US10392413B2Aug 27, 2019
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
ARDELYX INC3 citations71
US10376481B2Aug 13, 2019
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC3 citations71
US9006281B2Apr 14, 2015
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC1 citations62
US8969377B2Mar 3, 2015
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC3 citations62
US12084472B2Sep 10, 2024
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
ARDELYX INC0 citations50